ATB-239

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameATB-239
Drug Alias NameATB-239
ClassificationSmall molecules > Autophagy-Targeting Chimeras (AUTOTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAutotac Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAutotac Bio Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A